Cancer-related fatigue in elderly patients

Annalisa Giacalone, Daniela Quitadamo, Umberto Tirelli, Simon Spazzapan

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Fatigue is one of the most common and debilitating symptoms experienced by cancer patients and cancer survivors (incidence 20-90%). Cancer-related fatigue involves all the phases of cancer, even after the discontinuation of treatments. It may worsen the quality of life, force the patient to give up treatment and increase Health Care costs. Research has shown that cancer-related fatigue has a multi-factorial aetiology that necessitates appropriate pharmacological and/or non-pharmacological treatments based on the correct evaluation of the symptoms and the pre-existing causes e.g. anaemia, endocrine, metabolic and mood disorders. Even if fatigue rates of between 70 and 99% occur in patients older than 70 years, this has not translated into an increase in clinical trials for the assessment and therapy of cancer-related fatigue in this population group. The early recognition and formal assessment of this symptom in a population group with a high risk for frailty is important in order to be able to treat it before it impacts negatively on the patient's quality of life. This chapter aims to give a brief overview of cancer-related fatigue in elderly cancer patients.

Original languageEnglish
Title of host publicationCancer in the Elderly
PublisherNova Science Publishers, Inc.
Pages1-32
Number of pages32
ISBN (Print)9781614706380
Publication statusPublished - Mar 2012

Fingerprint

Fatigue
Fatigue of materials
Neoplasms
Symptom Assessment
Population Groups
Quality of Life
Second Primary Neoplasms
Health care
Mood Disorders
Health Care Costs
Survivors
Anemia
Therapeutics
Clinical Trials
Pharmacology
Incidence
Costs
Research

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Medicine(all)

Cite this

Giacalone, A., Quitadamo, D., Tirelli, U., & Spazzapan, S. (2012). Cancer-related fatigue in elderly patients. In Cancer in the Elderly (pp. 1-32). Nova Science Publishers, Inc..

Cancer-related fatigue in elderly patients. / Giacalone, Annalisa; Quitadamo, Daniela; Tirelli, Umberto; Spazzapan, Simon.

Cancer in the Elderly. Nova Science Publishers, Inc., 2012. p. 1-32.

Research output: Chapter in Book/Report/Conference proceedingChapter

Giacalone, A, Quitadamo, D, Tirelli, U & Spazzapan, S 2012, Cancer-related fatigue in elderly patients. in Cancer in the Elderly. Nova Science Publishers, Inc., pp. 1-32.
Giacalone A, Quitadamo D, Tirelli U, Spazzapan S. Cancer-related fatigue in elderly patients. In Cancer in the Elderly. Nova Science Publishers, Inc. 2012. p. 1-32
Giacalone, Annalisa ; Quitadamo, Daniela ; Tirelli, Umberto ; Spazzapan, Simon. / Cancer-related fatigue in elderly patients. Cancer in the Elderly. Nova Science Publishers, Inc., 2012. pp. 1-32
@inbook{9fcfcfb70c46489da73e95d92496845b,
title = "Cancer-related fatigue in elderly patients",
abstract = "Fatigue is one of the most common and debilitating symptoms experienced by cancer patients and cancer survivors (incidence 20-90{\%}). Cancer-related fatigue involves all the phases of cancer, even after the discontinuation of treatments. It may worsen the quality of life, force the patient to give up treatment and increase Health Care costs. Research has shown that cancer-related fatigue has a multi-factorial aetiology that necessitates appropriate pharmacological and/or non-pharmacological treatments based on the correct evaluation of the symptoms and the pre-existing causes e.g. anaemia, endocrine, metabolic and mood disorders. Even if fatigue rates of between 70 and 99{\%} occur in patients older than 70 years, this has not translated into an increase in clinical trials for the assessment and therapy of cancer-related fatigue in this population group. The early recognition and formal assessment of this symptom in a population group with a high risk for frailty is important in order to be able to treat it before it impacts negatively on the patient's quality of life. This chapter aims to give a brief overview of cancer-related fatigue in elderly cancer patients.",
author = "Annalisa Giacalone and Daniela Quitadamo and Umberto Tirelli and Simon Spazzapan",
year = "2012",
month = "3",
language = "English",
isbn = "9781614706380",
pages = "1--32",
booktitle = "Cancer in the Elderly",
publisher = "Nova Science Publishers, Inc.",

}

TY - CHAP

T1 - Cancer-related fatigue in elderly patients

AU - Giacalone, Annalisa

AU - Quitadamo, Daniela

AU - Tirelli, Umberto

AU - Spazzapan, Simon

PY - 2012/3

Y1 - 2012/3

N2 - Fatigue is one of the most common and debilitating symptoms experienced by cancer patients and cancer survivors (incidence 20-90%). Cancer-related fatigue involves all the phases of cancer, even after the discontinuation of treatments. It may worsen the quality of life, force the patient to give up treatment and increase Health Care costs. Research has shown that cancer-related fatigue has a multi-factorial aetiology that necessitates appropriate pharmacological and/or non-pharmacological treatments based on the correct evaluation of the symptoms and the pre-existing causes e.g. anaemia, endocrine, metabolic and mood disorders. Even if fatigue rates of between 70 and 99% occur in patients older than 70 years, this has not translated into an increase in clinical trials for the assessment and therapy of cancer-related fatigue in this population group. The early recognition and formal assessment of this symptom in a population group with a high risk for frailty is important in order to be able to treat it before it impacts negatively on the patient's quality of life. This chapter aims to give a brief overview of cancer-related fatigue in elderly cancer patients.

AB - Fatigue is one of the most common and debilitating symptoms experienced by cancer patients and cancer survivors (incidence 20-90%). Cancer-related fatigue involves all the phases of cancer, even after the discontinuation of treatments. It may worsen the quality of life, force the patient to give up treatment and increase Health Care costs. Research has shown that cancer-related fatigue has a multi-factorial aetiology that necessitates appropriate pharmacological and/or non-pharmacological treatments based on the correct evaluation of the symptoms and the pre-existing causes e.g. anaemia, endocrine, metabolic and mood disorders. Even if fatigue rates of between 70 and 99% occur in patients older than 70 years, this has not translated into an increase in clinical trials for the assessment and therapy of cancer-related fatigue in this population group. The early recognition and formal assessment of this symptom in a population group with a high risk for frailty is important in order to be able to treat it before it impacts negatively on the patient's quality of life. This chapter aims to give a brief overview of cancer-related fatigue in elderly cancer patients.

UR - http://www.scopus.com/inward/record.url?scp=84892128507&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84892128507&partnerID=8YFLogxK

M3 - Chapter

AN - SCOPUS:84892128507

SN - 9781614706380

SP - 1

EP - 32

BT - Cancer in the Elderly

PB - Nova Science Publishers, Inc.

ER -